Filing Flows › PAVmed (PAVM) › Who owns the stock
Who owns PAVmed (PAVM) stock
20 funds reported PAVmed (PAVM) shares in their latest 13F filings, worth $4.5M in all. The largest holder is First Manhattan Co. LLC. ($2.0M). Last quarter 9 funds added to their stakes and 8 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| First Manhattan Co. LLC. | 332,911 | $2.0M | increase | 2026-06-30 |
| Two Seas Capital LP | 461,539 | $1.7M | unchanged | 2026-09-30 |
| Vanguard Capital Management LLC | 61,604 | $366K | increase | 2026-06-30 |
| Geode Capital Management, LLC | 36,678 | $218K | increase | 2026-06-30 |
| Vanguard Fiduciary Trust | 25,605 | $152K | increase | 2026-06-30 |
| BlackRock | 17,092 | $102K | increase | 2026-06-30 |
| CWM, LLC | 157 | $2K | new | 2026-03-31 |
| Morgan Stanley | 163 | $1K | decrease | 2026-06-30 |
| SBI Securities | 67 | $398 | unchanged | 2026-06-30 |
| UBS Group AG | 57 | $339 | decrease | 2026-06-30 |
| Wells Fargo | 45 | $267 | unchanged | 2026-06-30 |
| Allworth Financial LP | 5 | $30 | decrease | 2026-06-30 |
| Federation des caisses Desjardins du Quebec | 4 | $23 | new | 2026-06-30 |
| Osaic Holdings | 4 | $21 | unchanged | 2026-06-30 |
| Steward Partners Investment Advisory, LLC | 2 | $12 | increase | 2026-06-30 |
PAVmed's latest quarter
PAVmed, Q2 2026: revenue $33K (+450% year over year), net loss $6.6M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most PAVM stock?
By the latest 13F filings: First Manhattan Co. LLC. ($2.0M); Two Seas Capital LP ($1.7M); Vanguard Capital Management LLC ($366K); Geode Capital Management, LLC ($218K); Vanguard Fiduciary Trust ($152K).
What is the short interest in PAVM?
12,717 shares were sold short at the 2026-10-15 settlement, 0.76% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.